Pharmaceuticals & Life Sciences

Türkiye’s pharmaceutical and life sciences sector is one of the most developed in the region, supported by strong manufacturing capabilities, a large domestic market, and alignment with EU regulations.

Domestic Market & Production With a population of over 85 million and a universal healthcare system, Türkiye offers a strong pharmaceutical market. Over 80% of prescriptions are produced domestically. The country has more than 90 production facilities, many of which hold EU GMP certifications.

Export Hub Potential Türkiye exports pharmaceuticals to over 180 countries, with a growing footprint in MENA, CIS, and Sub-Saharan Africa. Local manufacturers are expanding into biotechnology, generics, OTC, and vaccines.

Clinical Research & Innovation Türkiye is becoming a regional base for clinical trials due to its large and diverse patient pool, qualified medical personnel, and cost efficiency. R&D centers are growing, particularly in biosimilars, oncology, and rare diseases.

Health Investment Ecosystem Government incentives support investments in R&D, technology transfer, localization, and medical production zones. Collaborations between pharmaceutical companies, universities, and research institutes are deepening.